A mouse model of human ZNF198-fibroblast growth factor receptor-1 (FGFR1) stemcellleukemia lymphoma has been developed to investigate mechanisms of oncogenesis and progression.
1
This group of patients is supplemented in addition by non- and lateresponders and children with acuteundifferentiatedleukemia (AUL).
1
These cells are thought to be responsible for relapse and are termed leukemiastemcells (LSCs).
2
Leukemia progression and relapse is fueled by leukemiastemcells (LSC) that are resistant to current treatments.
3
Specific identification of leukemiastemcells and their discrimination from normal hematopoietic stem cells would greatly contribute to risk stratification and could predict possible relapses.